10Elms LLP’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.46M Buy
183,989
+85,935
+88% +$2.08M 1.89% 15
2026
Q1
$2.38M Buy
98,054
+61,489
+168% +$1.49M 1.5% 20
2025
Q4
$888K Sell
36,565
-110
-0.3% -$2.67K 0.81% 26
2025
Q3
$893K Buy
36,675
+1,850
+5% +$44.9K 0.8% 26
2025
Q2
$845K Buy
34,825
+2,005
+6% +$48.4K 0.8% 24
2025
Q1
$794K Buy
32,820
+6,750
+26% +$162K 0.8% 25
2024
Q4
$625K Buy
+26,070
New +$628K 0.65% 34

Other funds holding IBDS

10Elms LLP's IBDS Position: Q2 2026 in Review

10Elms LLP increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 88% in Q2 2026, buying an estimated $2.08M and bringing the position to 183,989 shares worth $4.46M. The position accounts for 1.89% of the portfolio, ranked #15.

10Elms LLP first reported a position in IBDS in Q4 2024 and has held it in 7 quarters since. 416 funds tracked by Wall St. Rank hold IBDS as of Q2 2026.

  • 10Elms LLP held 183,989 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $4.46M as of Q2 2026.
  • 10Elms LLP bought 85,935 iShares iBonds Dec 2027 Term Corporate ETF shares in Q2 2026, an estimated $2.08M.
  • iShares iBonds Dec 2027 Term Corporate ETF made up 1.89% of 10Elms LLP's portfolio in Q2 2026, its #15 holding.
  • 10Elms LLP first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q4 2024 and has held it in 7 quarters since.
  • 416 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q2 2026.

Based on 10Elms LLP's 13F filing for Q2 2026, filed 14 Aug 2026.